Biologics vs Small Molecules: What the Cost and Supply Differences Mean
Why some drugs cost pennies per dose and others cost tens of thousands per patient—and how those economics reshape procurement, negotiation and supply chain risk. … Read more
Industry Intelligence
Pharmaceutical product news covering prescription and OTC drugs, generics, biologics and supplements — approvals, pipeline developments, shortages and pricing.
Why some drugs cost pennies per dose and others cost tens of thousands per patient—and how those economics reshape procurement, negotiation and supply chain risk. … Read more
The most misunderstood number in healthcare finance—and how a drug can have a $1,000 list price and a $300 net price, paid by different buyers … Read more
Inside the global API supply chain: where drug ingredients are made, why China and India dominate, and what concentration risk means for buyers. Every medicine … Read more